A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...

The program's expansion is being funded by money Orange County received through national legal settlements with opioid ...

Drug experts Drs. Volkow and McLellan set out a road map to reverse the opioid epidemic in 2016. Find out how we're doing now ...

Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

Pat George, chairman of the Kansas Fights Addiction Act Grant Review Board, gives an update to the Senate Ways and Means ...

This painkiller's approval reflects the FDA’s commitment to expanding non-opioid pain treatment options ... where opioid addiction has become a major public health issue. With an effective ...